Health Care : Current Reviews

Colorectal Cancer: Screening options, recommendations and the role of biomarkers

International Congress on Global Healthcare

August 24-25, 2023 | WEBINAR

Maleesha Rasanji Jayasinghe

Nanjing Medical University, China

Scientific Tracks Abstracts: Health Care Curr Rev

Abstract:

Colorectal cancer (CRC) is the fourth most common malignancy, accounting for 10% of all new cancer cases. Twenty-five percent of patients are diagnosed at an advanced stage, with a five-year overall survival rate of only 14%. Routine CRC screening is recommended for adults at average risk beginning at the age of 45 because it is a common and preventable cancer. Various screening techniques, with different sensitivity and specificity, are currently in use, ranging from stool-based testing to radiologic tests and visual endoscopic examinations. Biomarkers also play a crucial role in determining the recurrence of CRC. This study provides an overview of all the available screening options, including biomarkers for CRC detection, as well as the benefits and challenges encompassing each screening modality.

Biography :

Maleesha Jayasinghe is a fifth year medical student enrolled at Nanjing Medical University. She served as her school’s captain and is now a student representative at her medical school. She is fluent in three languages. She enjoys playing badminton, socializing with her friends, and playing the piano during her spare time. She has a passion for research. She seeks out new learning opportunities constantly because she enjoys acquiring new knowledge.